Cordasco Financial Network’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cordasco Financial Network’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$5K	Hold	173	–	–	﹤0.01%	446
2022 Q1	$8K	Buy	+173	New	+$8.25K	0.01%	392
2019 Q4	–	Sell	-2,000	Closed	-$59K	–	448
2019 Q3	$59K	Hold	2,000	–	–	0.06%	116
2019 Q2	$69K	Hold	2,000	–	–	0.07%	104
2019 Q1	$66K	Hold	2,000	–	–	0.07%	107
2018 Q4	$48K	Buy	+2,000	New	+$56.4K	0.05%	117

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Cordasco Financial Network's ARKG Position: Q2 2022 in Review

Cordasco Financial Network held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2022 at 173 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

Cordasco Financial Network first reported a position in ARKG in Q4 2018 and has held it in 6 quarters since. The position peaked at $69K in Q2 2019. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Cordasco Financial Network held 173 shares of ARK Genomic Revolution ETF worth $5K as of Q2 2022.
Cordasco Financial Network left its ARK Genomic Revolution ETF share count unchanged in Q2 2022.
ARK Genomic Revolution ETF made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #446 holding.
Cordasco Financial Network first reported a position in ARK Genomic Revolution ETF in Q4 2018 and has held it in 6 quarters since.
Cordasco Financial Network's ARK Genomic Revolution ETF position peaked at $69K in Q2 2019.
334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.